
Matthew Justin Todd MD
Hospital Medicine/Hospitalist
Instructor, Clinical Education-Chattanooga, University of Tennessee Health
Join to View Full Profile
975 E 3rd StChattanooga, TN 37403
Phone+1 423-778-3274
Fax+1 423-778-2255
Are you Dr. Todd?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Todd, MD is a board certified internist in Chattanooga, Tennessee. He is currently licensed to practice medicine in Tennessee and Georgia. He is an Instructor at University of Tennessee Health.
Education & Training
- University of Tennessee College of Medicine at ChattanoogaResidency, Internal Medicine, 2000 - 2003
- Medical College of Georgia at Augusta UniversityClass of 2000
Certifications & Licensure
- TN State Medical License 2002 - 2026
- TN State Medical License 2002 - 2026
- GA State Medical License 2014 - 2019
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 87 citationsThe use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.Jenson Qi, Wensheng Lang, John G. Geisler, Ping Wang, Ioanna P. Petrounia
Journal of Lipid Research. 2012-06-01 - 9 citationsScreening and characterization of human monoglyceride lipase active site inhibitors using orthogonal binding and functional assays.Jose C. Clemente, Erica L Nulton, Marina I. Nelen, Matthew J. Todd, Diane M. Maguire
Journal of Biomolecular Screening. 2012-04-06 - 21 citationsA novel fluorogenic substrate for the measurement of endothelial lipase activityAndrew L. Darrow, Matthew Wayne Olson, Hong Xin, Sharon L. Burke, Charles Smith
Journal of Lipid Research. 2011-02-01
Press Mentions
- KHN Morning BriefingMarch 24th, 2023
- Crystal Structures of the Novel Coronavirus Protease Guide Drug DevelopmentMarch 24th, 2020